Data was released from Krakow Poland at the International Meeting on the use of Autologous Growth Factors in Orthopaedics and Sports Medicine: “State of the Art” – Krakow, Poland – 24 April 2009. The study found that patients receiving cortisone showed a 40% improvement compared to PRP 75% at 12 months. This is the first head to head study. Cortisone is well known to carry a risk of weakening & rupturing a tendon & is often discouraged.
We are conducting a multicenter FDA approved trial on tennis elbow beginning Mid June 2009.